Article Text

Download PDFPDF
Response to: ‘Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia’ by Wan et al
  1. Jixin Zhong,
  2. Lingli Dong
  1. Department of Rheumatology and Immunlogy, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
  1. Correspondence to Professor Jixin Zhong, Department of Rheumatology and Immunlogy, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China; zhongjixin620{at}163.com; Dr Lingli Dong, Department of Rheumatology and Immunlogy, ongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China; tjhdongll{at}163.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We thank Dr. Wan and colleagues for their comments on our manuscript reporting the clinical features of COVID-19 pneumonia in patients with rheumatic disease.1 Wan et al analysed 569 cases of COVID-19 in Sarawak, Malaysia and found 4 patients with rheumatic diseases (2 systemic lupus erythematosus, 1 dermatomyositis, and 1 scleroderma). Among these four patients with COVID-19 and rheumatic disease, they noted one case requiring ventilation (25%, 1/4) and one case developing an SLE flare at admission (25%, 1/4). These were in agreement with our findings that respiratory failure was more common in patients with COVID-19 with rheumatic disease (38% vs 10%, p<0.001) and some patients with COVID-19 and rheumatic disease may experience a flare of …

View Full Text

Linked Articles